Discover the full record of transactions filed by Vogt Frederick G, 首席执行官. Director active across 1 company, notably Iovance Biotherapeutics, INC.. Aggregated, 26 reports have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €50k. History available since 1 June 2022. The latest transaction was filed on 8 September 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Vogt Frederick G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Vogt Frederick G is Interim CEO & General Counsel at Iovance Biotherapeutics, INC. He has 22 filings in total, and across the recent filings observed between 2022-06-02 and 2026-03-06, buys amount to EUR 49597 and sells to EUR 0, with option exercises as the most common transaction type.